Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intervening to reduce the risk of future disability from multiple sclerosis: are we there yet?
Dahdaleh M, Alroughani R, Aljumah M, AlTahan A, Alsharoqi I, Bohlega SA, Daif A, Deleu D, Inshasi J, Karabudak R, Sahraian MA, Taha K, Yammout BI, Zakaria M. Dahdaleh M, et al. Among authors: bohlega sa. Int J Neurosci. 2017 Oct;127(10):944-951. doi: 10.1080/00207454.2016.1277424. Epub 2017 Jan 12. Int J Neurosci. 2017. PMID: 28029270 Review.
Neurodegenerative Huntington-like disorder.
Bohlega S, Al-Tahan A, Kambouris M, Divakaran M. Bohlega S, et al. Mov Disord. 2001 May;16(3):533-4. doi: 10.1002/mds.1079. Mov Disord. 2001. PMID: 11391753 No abstract available.
A recommended treatment algorithm in relapsing multiple sclerosis: report of an international consensus meeting.
Karussis D, Biermann LD, Bohlega S, Boiko A, Chofflon M, Fazekas F, Freedman M, Gebeily S, Gouider R, Havrdova E, Jakab G, Karabudak R, Miller A; International Working Group for Treatment Optimization in MS. Karussis D, et al. Eur J Neurol. 2006 Jan;13(1):61-71. doi: 10.1111/j.1468-1331.2006.01147.x. Eur J Neurol. 2006. PMID: 16420394 Review.
Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosis.
Goodin DS, Biermann LD, Bohlega S, Boiko A, Chofflon M, Gebeily S, Gouider R, Havrdova E, Jakab G, Karabudak R, Karussis D, Miller A, Pakdaman H, Selmaj K, Sharief M; International Working Group for Treatment Optimization in MS. Goodin DS, et al. Curr Med Res Opin. 2007 Nov;23(11):2823-32. doi: 10.1185/03007x233007. Curr Med Res Opin. 2007. PMID: 17908370 Review.
Biosimilars: opinion of an expert panel in the Middle East.
Bohlega S, Al-Shammri S, Al Sharoqi I, Dahdaleh M, Gebeily S, Inshasi J, Khalifa A, Pakdaman H, Szólics M, Yamout B. Bohlega S, et al. Curr Med Res Opin. 2008 Oct;24(10):2897-903. doi: 10.1185/03007990802381554. Epub 2008 Sep 2. Curr Med Res Opin. 2008. PMID: 18768104 Review.
Consensus guidelines for the diagnosis and treatment of multiple sclerosis.
Yamout B, Alroughani R, Al-Jumah M, Khoury S, Abouzeid N, Dahdaleh M, Alsharoqi I, Inshasi J, Hashem S, Zakaria M, ElKallab K, Alsaadi T, Tawfeek T, Bohlega S. Yamout B, et al. Curr Med Res Opin. 2013 Jun;29(6):611-21. doi: 10.1185/03007995.2013.787979. Epub 2013 Apr 22. Curr Med Res Opin. 2013. PMID: 23514115
142 results